These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 20176740)

  • 21. Inhibition of osteoclast differentiation and bone resorption by sauchinone.
    Han KY; Yang D; Chang EJ; Lee Y; Huang H; Sung SH; Lee ZH; Kim YC; Kim HH
    Biochem Pharmacol; 2007 Sep; 74(6):911-23. PubMed ID: 17662251
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transforming growth factor beta affects osteoclast differentiation via direct and indirect actions.
    Quinn JM; Itoh K; Udagawa N; Hausler K; Yasuda H; Shima N; Mizuno A; Higashio K; Takahashi N; Suda T; Martin TJ; Gillespie MT
    J Bone Miner Res; 2001 Oct; 16(10):1787-94. PubMed ID: 11585342
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sesquiterpene lactone parthenolide blocks lipopolysaccharide-induced osteolysis through the suppression of NF-kappaB activity.
    Yip KH; Zheng MH; Feng HT; Steer JH; Joyce DA; Xu J
    J Bone Miner Res; 2004 Nov; 19(11):1905-16. PubMed ID: 15476591
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Paeonol inhibits RANKL-induced osteoclastogenesis by inhibiting ERK, p38 and NF-kappaB pathway.
    Tsai HY; Lin HY; Fong YC; Wu JB; Chen YF; Tsuzuki M; Tang CH
    Eur J Pharmacol; 2008 Jun; 588(1):124-33. PubMed ID: 18495114
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysis of the kinetics of osteoclastogenesis in arthritic rats.
    Schett G; Stolina M; Bolon B; Middleton S; Adlam M; Brown H; Zhu L; Feige U; Zack DJ
    Arthritis Rheum; 2005 Oct; 52(10):3192-201. PubMed ID: 16200623
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increase in expression of receptor activator of nuclear factor kappaB at sites of bone erosion correlates with progression of inflammation in evolving collagen-induced arthritis.
    Lubberts E; Oppers-Walgreen B; Pettit AR; Van Den Bersselaar L; Joosten LA; Goldring SR; Gravallese EM; Van Den Berg WB
    Arthritis Rheum; 2002 Nov; 46(11):3055-64. PubMed ID: 12428250
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 12-O-tetradecanoylphorbol-13-acetate (TPA) inhibits osteoclastogenesis by suppressing RANKL-induced NF-kappaB activation.
    Wang C; Steer JH; Joyce DA; Yip KH; Zheng MH; Xu J
    J Bone Miner Res; 2003 Dec; 18(12):2159-68. PubMed ID: 14672351
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Erythromycin inhibits wear debris-induced osteoclastogenesis by modulation of murine macrophage NF-kappaB activity.
    Ren W; Li XH; Chen BD; Wooley PH
    J Orthop Res; 2004 Jan; 22(1):21-9. PubMed ID: 14656655
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand.
    Kong YY; Feige U; Sarosi I; Bolon B; Tafuri A; Morony S; Capparelli C; Li J; Elliott R; McCabe S; Wong T; Campagnuolo G; Moran E; Bogoch ER; Van G; Nguyen LT; Ohashi PS; Lacey DL; Fish E; Boyle WJ; Penninger JM
    Nature; 1999 Nov; 402(6759):304-9. PubMed ID: 10580503
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Class A scavenger receptor promotes osteoclast differentiation via the enhanced expression of receptor activator of NF-kappaB (RANK).
    Takemura K; Sakashita N; Fujiwara Y; Komohara Y; Lei X; Ohnishi K; Suzuki H; Kodama T; Mizuta H; Takeya M
    Biochem Biophys Res Commun; 2010 Jan; 391(4):1675-80. PubMed ID: 20036645
    [TBL] [Abstract][Full Text] [Related]  

  • 31. RANK is the essential signaling receptor for osteoclast differentiation factor in osteoclastogenesis.
    Nakagawa N; Kinosaki M; Yamaguchi K; Shima N; Yasuda H; Yano K; Morinaga T; Higashio K
    Biochem Biophys Res Commun; 1998 Dec; 253(2):395-400. PubMed ID: 9878548
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intravenously delivered glucocorticoid liposomes inhibit osteoclast activity and bone erosion in murine antigen-induced arthritis.
    Hofkens W; Grevers LC; Walgreen B; de Vries TJ; Leenen PJ; Everts V; Storm G; van den Berg WB; van Lent PL
    J Control Release; 2011 Jun; 152(3):363-9. PubMed ID: 21396411
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulatory T cells protect from local and systemic bone destruction in arthritis.
    Zaiss MM; Frey B; Hess A; Zwerina J; Luther J; Nimmerjahn F; Engelke K; Kollias G; Hünig T; Schett G; David JP
    J Immunol; 2010 Jun; 184(12):7238-46. PubMed ID: 20483756
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adipose-Derived Mesenchymal Stem Cells Prevent Systemic Bone Loss in Collagen-Induced Arthritis.
    Garimella MG; Kour S; Piprode V; Mittal M; Kumar A; Rani L; Pote ST; Mishra GC; Chattopadhyay N; Wani MR
    J Immunol; 2015 Dec; 195(11):5136-48. PubMed ID: 26538398
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A possible suppressive role of galectin-3 in upregulated osteoclastogenesis accompanying adjuvant-induced arthritis in rats.
    Li YJ; Kukita A; Teramachi J; Nagata K; Wu Z; Akamine A; Kukita T
    Lab Invest; 2009 Jan; 89(1):26-37. PubMed ID: 19015643
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Water-soluble fullerene (C60) inhibits the osteoclast differentiation and bone destruction in arthritis.
    Yudoh K; Karasawa R; Masuko K; Kato T
    Int J Nanomedicine; 2009; 4():233-9. PubMed ID: 19918370
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Possible involvement of MIP-1alpha in the recruitment of osteoclast progenitors to the distal tibia in rats with adjuvant-induced arthritis.
    Toh K; Kukita T; Wu Z; Kukita A; Sandra F; Tang QY; Nomiyama H; Iijima T
    Lab Invest; 2004 Sep; 84(9):1092-102. PubMed ID: 15195117
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dietary emu oil supplementation suppresses 5-fluorouracil chemotherapy-induced inflammation, osteoclast formation, and bone loss.
    Raghu Nadhanan R; Abimosleh SM; Su YW; Scherer MA; Howarth GS; Xian CJ
    Am J Physiol Endocrinol Metab; 2012 Jun; 302(11):E1440-9. PubMed ID: 22436700
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phosphatidylserine nanoliposomes inhibit glucocorticoid-induced osteoporosis: A potential combination therapy with alendronate.
    Eskandarynasab M; Doustimotlagh AH; Takzaree N; Etemad-Moghadam S; Alaeddini M; Dehpour AR; Goudarzi R; Partoazar A
    Life Sci; 2020 Sep; 257():118033. PubMed ID: 32621924
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulation of osteoclastogenesis by Simon extracts composed of caffeic acid and related compounds: successful suppression of bone destruction accompanied with adjuvant-induced arthritis in rats.
    Tang QY; Kukita T; Ushijima Y; Kukita A; Nagata K; Sandra F; Watanabe T; Toh K; Okuma Y; Kawasaki S; Rasubala L; Teramachi J; Miyamoto I; Wu Z; Iijima T
    Histochem Cell Biol; 2006 Mar; 125(3):215-25. PubMed ID: 16205940
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.